Press

Tryp Therapeutics Announces Q3 2021 Financial Results

Jul 29 • 3 min read

Quick Take: Tryp Therapeutics has announced their Q3 2021 financial results, stating $6.1 million in assets including $5.6 million in cash Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the “Company“), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, announced today its interim financial results for…

Levitee Labs Announces Completion of Acquisition of BlockMD Telemedicine Platform

Jul 29 • 2 min read

Quick Take: Levitee Labs has acquired BlockMD, a telemedicine platform for patients with substance abuse disorders in western Canada. Levitee Labs Inc. (CSE: LVT) (the “Company” or “Levitee”), a biotechnology company with a diversified portfolio of healthcare and wellness assets, is pleased to announce that it has completed the acquisition of all the issued and outstanding shares of…

Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5

Jul 29 • 2 min read

Quick Take: Cybin has recieved approval for its common shares to be listed on the NYSE around August 5th. Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has received approval for the listing of its common shares on the NYSE American LLC stock exchange (“NYSE American”). The Company…

Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP

Jul 27 • 2 min read

Quick Take: Field Trip Health will begin trading on the NASDAQ beginning July 29. Field Trip Health Ltd. (TSX: FTRP) , a global leader in the development and delivery of psychedelic therapies, announced today that it has received final approval from The NASDAQ Stock Market LLC (“NASDAQ”) to list its common shares on the NASDAQ…

Awakn Life Sciences Commences Trading on the OTC Market on July 26, 2021 Under the Symbol ‘AWKNF’

Jul 26 • 2 min read

Quick Take: Awakn Life Sciences has received approval from the Financial Regulatory Authority to commence trading on the OTC market. Awakn Life Sciences Corp. (NEO: AWKN) (OTC Pink: AWKNF), a biotechnology company with clinical operations developing and delivering psychedelic medicines to better treat addiction, today announced approval from the Financial Regulatory Authority (“FINRA”) for its…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436